Catheter-related bloodstream infections in HIV-infected patients

Annals of the New York Academy of Sciences

Volumn 946, Issue , 2001, Pages 274-290

  Nicastri, Emanuele ^a   Petrosillo, Nicola ^a   Viale, Pierluigi ^b   Ippolito, Giuseppe ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Bloodstream infections; Central venous catheter; HIV AIDS; Nosocomial infection

Indexed keywords

ADHESIN; ALCOHOL; ANTIBIOTIC AGENT; CHLORHEXIDINE GLUCONATE; HEPARIN; MINOCYCLINE; NEOMYCIN; POLYMYXIN; POVIDONE IODINE; RIFABUTIN; RIFAMPICIN;

ACINETOBACTER; ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIUM CONTAMINATION; BLOOD CULTURE; CANDIDA; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONFERENCE PAPER; ENTEROCOCCUS; ERADICATION THERAPY; ESCHERICHIA COLI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; KLEBSIELLA PNEUMONIAE; MORTALITY; PSEUDOMONAS; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA;

ACINETOBACTER; BACTERIA (MICROORGANISMS); CANDIDA; ENTEROCOCCUS; ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS; KLEBSIELLA PNEUMONIAE; PSEUDOMONAS; RNA VIRUSES; STAPHYLOCOCCI; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA;

EID: 0035194246     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03917.x     Document Type: Conference Paper

References (95)

1. IV-related infections
2. Nosocomial bloodstream infections in critically ill patients. Excess length of stay, extra cost, and attributable mortality
3. Secular trends in nosocomial bloodstream infections in the United States, 1980-1989
4. Bacteremia in HIV-infected patients: Short term predictors of mortality
5. Peripherally inserted central catheters in patients with AIDS are associated with a low infection rate
6. Nosocomial infections in HIV infected patients
7. Infections related to central venous catheters
8. Bacteremia in HIV-positive and AIDS patients: Incidence, species distribution, risk-factors, outcome, and influence of long-term prophylactic antibiotic treatment
9. Nosocomial infections in HIV-infected patients: Preliminary results from a multicenter surveillance system (1989-1995)
10. Central venous catheter-relate sepsis: Epidemiology, pathogenesis, diagnosis, treatment and prevention
11. Guideline for prevention of intravascular device-related infections
12. Consequences of intravascular catheter sepsis
13. Specific problems of arterial Swan-Ganz and hemodialysis catheters
14. Total parenteral nutrition-related infections: Prospective epidemiologic study using semiquantitative methods
15. Vascular-access infections in hospitalized patients
16. The central venous catheter-related infections study group: Risk factors for central venous catheter-related infections in surgical and intensive care patients
17. Prospective study of catheter replacement and other risk factors for infection of hyperalimentation catheters
18. Septic and technical complications of central venous catheterization: A prospective study of 200 consecutive patients
19. Central catheter infections: Single vs. triple-lumen catheters; influence of guidelines on infection rates when used for replacement of catheters
20. Infection rate for single-lumen vs. triple-lumen subclavian catheters
21. Colonization and sepsis from triple-lumen catheters in critically ill patients
22. Prospective evaluation of single and triple lumen catheters in total parenteral nutrition
23. Single- versus triple-lumen central catheter-related sepsis: A prospective randomized study in a critically ill population
24. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: A prospective study utilizing molecular subtyping
25. Triple- vs single-lumen central venous catheters. A prospective study in a critically ill population
26. Long-term venous catheter infection in HIV-infected and cancer patients: A multicenter cohort study
27. Prior antimicrobials and staphylococcal bacteremia in HIV-infected patients
28. Morbidity associated with central venous catheter use in a cohort of 212 hospitalized subjects with HIV infection
29. Infectious morbidity associated with long-term use of venous access devices in patients with cancer
30. Catheter complications in AIDS patients treated for cytomegalovirus retinitis
31. HIV-associated bacteremia: How it has changed in the highly active antiretroviral therapy (HAART) era
32. Nontunneled central venous catheters in patients with AIDS are associated with a low infection rate
33. Infections associated with totally implantable venous access devices (TIVAD) in human immunodeficiency virus-infected patients
34. Risk factors for nasopharingeal colonization in with Staphylococcus aureus in HIV-infected outpatients
35. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990
36. Genotypic variation in slime production among blood and catheter isolates of Candida parapsilosis
37. Vascular catheter-related bloodstream infection due to Acinetobacter johnsonii (formerly Acinetobacter calcoaceticus var. lwoffi): Report of 13 cases
38. Tunneled-cuffed catheter associated infections in hemodialysis patients who are positive for the human immunodeficiency virus
39. Gram-negative bacillary bacteremia in human immunodeficiency type-1 infected children
40. Nosocomial infections in HIV-infected/AIDS patients
41. Predictive value of surveillance skin cultures in total parenteral nutrition-related infection. Prospective epidemiologic study using semi-quantitative cultures
42. Rapid diagnosis of intravascular catheter-associated infection by direct gram staining of catheter segments
43. Source and route of microbial colonization of parenteral nutrition catheters
44. A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates
45. A randomized trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition
46. Ultrastructural analysis of indwelling vascular catheters: A quantitative relationship between luminal colonization and duration of placement
47. Bacterial adherence to intravenous catheters and needles and its influence by cannula type and bacterial surface hydrophobicity
48. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material
49. Molecular mechansms of Staphylococcus epidermidis biofilm formation
50. Interference with granulocyte function by Staphylococcus epidermidis slime
51. Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response
52. Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics
53. Adherence and receptor relationships of Candida albicans
54. Peripheral access options
55. Low infection rate and long durability of nontunneled silastic catheters
56. Infections caused by central venous catheters in patients with acquired immunodeficiency syndrome
57. Quantitative intra venous catheter cultures identify focus of bacteremia
58. A semiquantitative culture method for identifying intravenous-catheter-related infection
59. Diagnosis of vascular catheter-related bloodstream infections: A meta-analysis
60. Diagnosis of catheter-related bacteraemia: A prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures
61. Validity of earlier positivity of central venous blood cultures in comparison with peripheral blood cultures for diagnosing catheter-related bacteremia in cancer patients
62. Rapid diagnosis of central-venous-catheter-related bloodstream infection without catheter removal
63. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis
64. Prevalence of infection from subclavian dialysis catheters with two different post-insertion catheter cares: A randomized comparative study
65. Successful use of cuffed central venous hemodialysis catheters inserted percutaneously
66. Optimal management of central venous catheter-related infections - What is the evidence?
67. In situ management of confirmed central venous catheter-related bacteremia
68. Results of antibiotic treatment of Hickman-catheter-related infections in oncological patients
69. Impact of central venous catheter removal on the recurrence of catheter related coagulase-negative staphylococcal bacteraemia
70. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: Increasing incidence of catheter-related infections
71. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study
72. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home
73. Antibiotic-lock technique: A new approach to optimal therapy for catheter-related sepsis in home parenteral nutrition patients
74. Successful treatment of haemodialysis catheter-related sepsis without catheter removal
75. Morbidity associated with long-term use of totally implantable ports in patients with AIDS
76. Antibiotic-lock technique: An alternative therapeutic approach to central venous catheter related bacteremia
77. Adjunctive antibiotic/anticoagulant lock therapy in the treatment of bacteremia associated with the use of a subcutaneously implanted hemodialysis access device
78. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer
79. Antibiotic-heparin lock: In vitro antibiotic stability combined with heparin in a central venous catheter
80. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion
81. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection
82. Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters
83. Use of a chlorhexidine dressing to reduce microbial colonization of epidural catheters
84. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and blood stream infections. A randomized, double-blind trial
85. Prevention of central venous catheter-related blood stream infections by use of an antiseptic-impregnated catheter. A randomized, controlled trial
86. A comparison of two antimicrobial-impregnated central venous catheters
87. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia
88. An attachable silver-impregnated cuff for the prevention of infection with central venous catheters: A prospective randomized multicenter trial
89. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection
90. Efficacy of subcutaneous silver-impregnated cuffs in preventing central venous catheter infections
91. Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: Silver ring prophylaxis at the catheter exit study
92. In vitro cytotoxicity of silver-impregnated collagen cuffs designed to decrease infection in tunneled catheters
93. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms
94. Prevention of intravascular catheter-related infections
95. Molecular epidemiology of an outbreack of fulminant hepatitis B